Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.33 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.33 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 5/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.32 |
| ▸ | GAA | P10253 | 3/20 | 0.32 |
| ▸ | LIPE | Q05469 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18228936 | 1.00 | MAPT (0.35) | MAPTADRB2ADRB1ADRB3MEN1 | |
| SCHEMBL18228935 | 1.00 | MAPT (0.35) | MAPTADRB2ADRB1ADRB3MEN1 | |
| SCHEMBL8222724 | 1.00 | MAPT (0.35) | MAPTADRB2ADRB1ADRB3MEN1 | |
| SCHEMBL8222908 | 0.96 | ADRB2 (0.36) | MAPTADRB2ADRB1ADRB3MEN1 | |
| SCHEMBL18228940 | 0.96 | ADRB2 (0.36) | MAPTADRB2ADRB1ADRB3MEN1 | |
| SCHEMBL10321994 | 0.96 | ADRB2 (0.36) | MAPTADRB2ADRB1ADRB3MEN1 | |
| SCHEMBL18228941 | 0.96 | ADRB2 (0.36) | MAPTADRB2ADRB1ADRB3MEN1 | |
| SCHEMBL692443 | 0.86 | ADRB2 (0.33) | MAPTADRB2ADRB1ADRB3ALDH1A1 | |
| SCHEMBL31412820 | 0.86 | ADRB2 (0.33) | MAPTADRB2ADRB1ADRB3ALDH1A1 | |
| SCHEMBL8223325 | 0.86 | ADRB2 (0.33) | MAPTADRB2ADRB1ADRB3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180078666-A1 | RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2018-03-22 | — | — | US | claimed |
| US-20130065969-A9 | Odour Compounds | GIVAUDAN SA (CH) | 2013-03-14 | — | — | US | claimed |
| US-20120184630-A1 | Odour Compounds | KRAFT PHILIP (CH) | 2012-07-19 | — | — | US | claimed |
| EP-2475639-A2 | ODOUR COMPOUNDS | Givaudan SA (CH) | 2012-07-18 | — | — | EP | claimed |
| WO-2011029895-A2 | ODOUR COMPOUNDS | GIVAUDAN SA (CH) | 2011-03-17 | — | — | WO | claimed |
| US-10576179-B2 | Relating to organic compounds | Givaudan, S.A. (CH) | 2020-03-03 | — | — | US | disclosed |
| US-20180078666-A1 | RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2018-03-22 | — | — | US | disclosed |
| EP-3294347-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2018-03-21 | — | — | EP | disclosed |
| WO-2016180893-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2016-11-17 | — | — | WO | disclosed |
| US-20130065969-A9 | Odour Compounds | GIVAUDAN SA (CH) | 2013-03-14 | — | — | US | disclosed |
| US-20120184630-A1 | Odour Compounds | KRAFT PHILIP (CH) | 2012-07-19 | — | — | US | disclosed |
| EP-2475639-A2 | ODOUR COMPOUNDS | Givaudan SA (CH) | 2012-07-18 | — | — | EP | disclosed |
| WO-2011029895-A2 | ODOUR COMPOUNDS | GIVAUDAN SA (CH) | 2011-03-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130065969-A9 | Odour Compounds | PRMT9, PRMT5, PRMT1 | MAPT 3368/4885ADRB2 543/4885ADRB1 527/4885 |
| US-20120184630-A1 | Odour Compounds | PRMT9, PRMT5, PRMT1 | MAPT 3368/4885ADRB2 543/4885ADRB1 527/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.